Spatio-temporal assessment of illicit drug use at large scale: evidence from seven years of international wastewater monitoring
File(s)add.14767 (1).pdf (5.37 MB)
Published version
OA Location
Author(s)
Barron, LP
Type
Journal Article
Abstract
Background and aims: Wastewater-based epidemiology is an additional indicator of drug use that is gaining reliability to complement the current established panel of indicators. The aims of this study were to (i) assess spatial and temporal trends of population-normalized mass loads of benzoylecgonine, amphetamine, methamphetamine, and 3,4-methylenedioxymethamphetamine (MDMA) in raw wastewater over seven years (2011-2017); (ii) address overall drug use by estimating the average number of combined doses consumed per day in each city. Design: Analysis of daily composite raw wastewater samples collected over one week per year from 2011 to 2017. Setting: Catchment areas of 143 wastewater treatment plants in 120 cities in 37 countries. Methods: Parent substances (amphetamine, methamphetamine, and MDMA) and the metabolites of cocaine (benzoylecgonine) and of Δ9-tetrahydrocannabinol (11-nor-9-carboxy-Δ9-tetrahydrocannabinol) were measured in wastewater using liquid chromatography-tandem mass spectrometry. Daily mass loads (mg/day) were normalized to catchment population (mg/1000 people/day) and converted to the number of combined doses consumed per day. Spatial differences were assessed worldwide, and temporal trends were discerned at European level by comparing 2011-2013 drug loads versus 2014-2017 loads. Findings: Benzoylecgonine was the stimulant metabolite detected at higher loads in southern and western Europe, and amphetamine, MDMA, and methamphetamine in the east and the north-centre of Europe. In other continents methamphetamine showed the highest levels in the United States and Australia and benzoylecgonine in South America. Over the reporting period, benzoylecgonine loads increased in general across Europe, amphetamine and methamphetamine levels fluctuated and MDMA underwent an intermittent upsurge. Conclusions: The analysis of wastewater to quantify drug loads provides updated and objective estimates of drug use that globally correspond to prevalence and seizure data. Additional strengths of this approach are its flexibility for application at different spatial and temporal scales, and the identification of consumption trends nearly in real time.
Date Issued
2020-01
Date Acceptance
2019-07-23
Citation
Addiction, 2020, 115 (1), pp.109-120
ISSN
0965-2140
Publisher
Wiley
Start Page
109
End Page
120
Journal / Book Title
Addiction
Volume
115
Issue
1
Copyright Statement
© 2019 The Authors. Addiction published by John Wiley & Sons Ltd on behalf of Society for the Study of Addiction
This is an open access article under the terms of the Creative Commons Attribution License, which permits use, distribution and reproduction in any medium, provided the original work is properly cited.
This is an open access article under the terms of the Creative Commons Attribution License, which permits use, distribution and reproduction in any medium, provided the original work is properly cited.
License URL
Identifier
https://onlinelibrary.wiley.com/doi/full/10.1111/add.14767
Subjects
Science & Technology
Life Sciences & Biomedicine
Substance Abuse
Psychiatry
Amphetamine
cocaine
ecstasy
MDMA
illicit drugs
methamphetamine
wastewater-based epidemiology
STIMULANT-DRUGS
AMPHETAMINE
METHAMPHETAMINE
CONSUMPTION
SEWAGE
METABOLITES
ABUSE
Amphetamine
cocaine
ecstasy/MDMA
illicit drugs
methamphetamine
wastewater-based epidemiology
Substance Abuse
11 Medical and Health Sciences
17 Psychology and Cognitive Sciences
Notes
Background and aims: Wastewater-based epidemiology is an additional indicator of drug use that is gaining reliability to complement the current established panel of indicators. The aims of this study were to (i) assess spatial and temporal trends of population-normalized mass loads of benzoylecgonine, amphetamine, methamphetamine, and 3,4-methylenedioxymethamphetamine (MDMA) in raw wastewater over seven years (2011-2017); (ii) address overall drug use by estimating the average number of combined doses consumed per day in each city. Design: Analysis of daily composite raw wastewater samples collected over one week per year from 2011 to 2017. Setting: Catchment areas of 143 wastewater treatment plants in 120 cities in 37 countries. Methods: Parent substances (amphetamine, methamphetamine, and MDMA) and the metabolites of cocaine (benzoylecgonine) and of Δ9-tetrahydrocannabinol (11-nor-9-carboxy-Δ9-tetrahydrocannabinol) were measured in wastewater using liquid chromatography-tandem mass spectrometry. Daily mass loads (mg/day) were normalized to catchment population (mg/1000 people/day) and converted to the number of combined doses consumed per day. Spatial differences were assessed worldwide, and temporal trends were discerned at European level by comparing 2011-2013 drug loads versus 2014-2017 loads. Findings: Benzoylecgonine was the stimulant metabolite detected at higher loads in southern and western Europe, and amphetamine, MDMA, and methamphetamine in the east and the north-centre of Europe. In other continents methamphetamine showed the highest levels in the United States and Australia and benzoylecgonine in South America. Over the reporting period, benzoylecgonine loads increased in general across Europe, amphetamine and methamphetamine levels fluctuated and MDMA underwent an intermittent upsurge. Conclusions: The analysis of wastewater to quantify drug loads provides updated and objective estimates of drug use that globally correspond to prevalence and seizure data. Additional strengths of this approach are its flexibility for application at different spatial and temporal scales, and the identification of consumption trends nearly in real time.
Publication Status
Published
Date Publish Online
2019-10-23